60541-86-8Relevant academic research and scientific papers
HETEROCYCLIC COMPOUND
-
Paragraph 0877; 0878, (2019/06/17)
Provided is a heterocyclic compound that may have a GCN2 inhibitory action, and is expected to be useful for the prophylaxis or treatment of GCN2 associated diseases including cancer and the like. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof.
HETEROARYL COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
-
Page/Page column 33-34, (2012/01/13)
The present invention provides compounds of Formula (I): wherein R1, R2, R3, and X are as defined herein. The compounds of Formula (I) and pharmaceutical compositions thereof are useful for the treatment of cancer, and B-
Sulfonylmethylamino-substituted benzoic acids and herbicidal method therewith
-
, (2008/06/13)
Novel benzoic acid compounds of the formula STR1 in which R is alkyl or substituted alkyl of up to 6 carbon atoms, where the substituents are selected from halogen, or R is aryl which is optionally substituted by halogen and/or by alkyl of up to 4 carbon atoms, R1 is alkyl, alkoxy or alkylmercapto, of in each case up to 4 carbon atoms, or halogen, R2 is hydrogen, R3 is hydrogen or halogen, R4 is hydroxyl, alkoxy of 1 to 6 carbon atoms or an amino group which is optionally substituted by one or two alkyl radicals each of up to 6 carbon atoms, and R5 is halogen or alkyl of up to 4 carbon atoms; are outstandingly effective and selective as herbicides.
